Abnormal Cannabidiol-d3
QUICK LINKS
Contains three deuterium atoms at the terminal methyl position. Intended for use as an internal standard for the quantification of compound by GC- or LC-mass spectrometry. A synthetic regioisomer of cannabidiol that fails to elicit either CB1 or CB2 responsiveness and is without psychotropic activity. Induces endothelium-dependent vasodilation via a CB1/CB2/nitric oxide-independent mechanism.2 Showed hypotensive activity that could not be antagonized by cannabidiol or SR141716A. Compound is therefore believed to activate a third type of CB receptor, provisionally called the non-CB1/CB2 endocannabinoid receptor. Also acts via these receptors to regulate the migratory activity of murine BV-2 microglial cells, with an EC50 value of 600 nM.3
Abnormal Cannabidiol-d3 References
1 Felder, C.C., Joyce, K.E., Briley, E.M., et al. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 48 443-450 (1995). 2 Járai, Z., Wagner, J.A., Varga, K., et al. Cannabinoid-induced meOrdering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Abnormal Cannabidiol-d3, 100 µg | sc-223766 | 100 µg | $62.00 | |||
Abnormal Cannabidiol-d3, 500 µg | sc-223766A | 500 µg | $280.00 | |||
Abnormal Cannabidiol-d3, 1 mg | sc-223766B | 1 mg | $497.00 | |||
Abnormal Cannabidiol-d3, 5 mg | sc-223766C | 5 mg | $2182.00 |